A randomized phase II study of capecitabine-based chemoradiation with or without bevacizumab in resectable locally advanced rectal cancer: clinical and biological features

BACKGROUND: Perioperatory chemoradiotherapy (CRT) improves local control and survival in patients with locally advanced rectal cancer (LARC). The objective of the current study was to evaluate the addition of bevacizumab (BEV) to preoperative capecitabine (CAP)-based CRT in LARC, and to explore biom...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:BMC Cancer
Glavni autori: Salazar, Ramon, Capdevila, Jaume, Laquente, Berta, Manzano, Jose Luis, Pericay, Carles, Villacampa, Mercedes Martínez, López, Carlos, Losa, Ferran, Safont, Maria Jose, Gómez, Auxiliadora, Alonso, Vicente, Escudero, Pilar, Gallego, Javier, Sastre, Javier, Grávalos, Cristina, Biondo, Sebastiano, Palacios, Amalia, Aranda, Enrique
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2015
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4343271/
https://ncbi.nlm.nih.gov/pubmed/25886378
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-015-1053-z
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items